Skip to main content

Table 5 Time of presentation of leprosy reaction among UMDT/CT-BR patients according to type of reaction

From: Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil

  At diagnosis
N (%)
In the 1st year after diagnosis
N (%)
Follow-up after 1st year
N (%)
Reaction-free
N (%)
Total
N (%)
RR 16 (22.5) 71 (34.6) 51 (35.9) NA 138 (18.3)
ENL 0 9 (4.4) 32 (22.5) NA 41 (5.4)
RR + Neu 6 (8.5) 15 (7.3) 7 (4.9) NA 28 (3.7)
ENL + Neu 3 (4.2) 3 (1.5) 1 (0.7) NA 7 (0.9)
Neuritis 43 (60.6) 77 (37.6) 29 (20.4) NA 149 (19.8)
Others 3 (4.2) 30 (14.6) 22 (15.5) NA 55 (7.3)
Total 71 (100) 205 (100) 142 (100) 335 (100) 753 (100)
  1. RR Reversal reaction, ENL Eritema Nodosum Leprosum, Neu neuritis, Others others manifestations